These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration. Wang ZY; Zhao KK; Song ZM; Shen LJ; Qu J Med Hypotheses; 2009 Apr; 72(4):448-50. PubMed ID: 19128888 [TBL] [Abstract][Full Text] [Related]
3. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development. Li H; Chintalapudi SR; Jablonski MM Expert Opin Investig Drugs; 2017 Oct; 26(10):1103-1114. PubMed ID: 28816076 [TBL] [Abstract][Full Text] [Related]
5. Current therapeutic developments in atrophic age-related macular degeneration. Hanus J; Zhao F; Wang S Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922 [TBL] [Abstract][Full Text] [Related]
6. Age-related macular degeneration: from neovascular to atrophic. Roy M; Kuehl E Ann Ophthalmol; 1989 Nov; 21(11):429-31. PubMed ID: 2482684 [TBL] [Abstract][Full Text] [Related]
7. [Current concepts in pathogenesis of age-related macular degeneration]. Kubicka-Trząska A; Karska-Basta I; Romanowska-Dixon B Klin Oczna; 2014; 116(4):277-82. PubMed ID: 25906640 [TBL] [Abstract][Full Text] [Related]
8. [Age-related macular degeneration; therapeutic options]. La Heij EC; Liem AT; Hendrikse F Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of imaging in atrophic macular degeneration and its use in clinical practice and clinical trial design. Lim PC; Layton CJ Clin Exp Ophthalmol; 2016 Jul; 44(5):410-21. PubMed ID: 26468964 [TBL] [Abstract][Full Text] [Related]
10. Macular ganglion cell complex and retinal nerve fiber layer comparison in different stages of age-related macular degeneration. Zucchiatti I; Parodi MB; Pierro L; Cicinelli MV; Gagliardi M; Castellino N; Bandello F Am J Ophthalmol; 2015 Sep; 160(3):602-607.e1. PubMed ID: 26052088 [TBL] [Abstract][Full Text] [Related]
11. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Richer S; Devenport J; Lang JC Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338 [TBL] [Abstract][Full Text] [Related]
12. Comparison of macular choroidal thickness among patients older than age 65 with early atrophic age-related macular degeneration and normals. Sigler EJ; Randolph JC Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6307-13. PubMed ID: 23982844 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of atrophic age-related macular degeneration. Mata NL; Vogel R Curr Opin Ophthalmol; 2010 May; 21(3):190-6. PubMed ID: 20216419 [TBL] [Abstract][Full Text] [Related]
15. [Age-related macular degeneration]. Van Bol L; Rasquin F Rev Med Brux; 2014 Sep; 35(4):265-70. PubMed ID: 25675629 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of single nucleotide polymorphisms in patients with atrophic age-related macular degeneration in oldest old Han Chinese. Zhou TQ; Guan HJ; Hu JY Genet Mol Res; 2015 Dec; 14(4):17432-8. PubMed ID: 26782385 [TBL] [Abstract][Full Text] [Related]
17. An update of treatment options for neovascular age-related macular degeneration. Iu LP; Kwok AK Hong Kong Med J; 2007 Dec; 13(6):460-70. PubMed ID: 18057435 [TBL] [Abstract][Full Text] [Related]
19. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Sunness JS Mol Vis; 1999 Nov; 5():25. PubMed ID: 10562649 [TBL] [Abstract][Full Text] [Related]
20. Treatment for atrophic macular degeneration. Meleth AD; Wong WT; Chew EY Curr Opin Ophthalmol; 2011 May; 22(3):190-3. PubMed ID: 21427574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]